glp-1 and migraines Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity chronic migraine. Participants reported an average Weight loss jab could be

13 As our understanding of their mechanisms continues to evolve, these agents offer promising new avenues for improving outcomes in HF patients.

Together, these programs create a full spectrum approach that improves metabolism, balances hormones, and builds a foundation for lasting vitality

New research published by Flinders University in September this year showed that out of 18,010 women aged 18-49 who attended general practices between 2011 and 2022 and were prescribed GLP-1 medications, only 21 per cent reported using contraception, and 2.2 per cent of women became pregnant within six months of starting GLP-1 treatment

First, we explore how exendin-4 from the Gila monster was developed into exenatide, the first GLP-1 medication

Antibodies against parietal cells (the cells lining the stomach that make intrinsic factor and stomach acid)